blue arrow
Return to news
Nov 2022

Updates to ACMG, WGS and much more in the newest AION release

Image above: Screenshot of AION showing a sample variant and its ACMG interpretation.

Author: Pablo Botas, PhD, Scientific Product Manager AION

On November 15th, we reached a new milestone in variant interpretation for rare diseases with the release of a major update to AION. In this update, we are powering our AI-based solution with a new infrastructure that can constantly update AION with the latest algorithms, pipeline improvements, public databases and data extracted from publications. This ensures that the latest insights are constantly integrated into AION. This is, however, not the only major update to AION.

Updates to ACMG implementation

Apply and remove criteria as you see fit dynamically updating ACMG classification. Criteria automatically applied by our ML algorithm can also be modified and are marked with a symbol for explicability. We also now automatically apply PS2, PVS1, PM2, PM3, and PM6.

An improved results view for easier interpretation

Disease symptoms are now shown, and those shared with the case are highlighted to help the user judge the clinical overlap. AION also now shows compound heterozygous candidates and second hits next to each other. Links have also been added to Orphanet, Pubmed search and Google Scholar search.

WGS interpretation

AION now supports WGS. The interpretation is performed in exomes ±50bp and known intronic variants. Support for larger files has also been improved, with significantly improved stability and speed in processing files that are over 1GB.

A brand new look and better user experience

We already liked the look of AION, but it got better. We updated the user interface, making AION even easier to use. Interfaces for case tables, the submitting process, case details and variant cards are overhauled, as well as an improved reporting functionality for errors.

We believe this is a huge step forward for our platform, but don’t take our word for it. Get in touch with us, and try out AION yourself. Find out more about AION, or talk to our team.

Want to know more?

Contact us!

arrow
Nostos Genomics Logo

Thank you, your submission was received.

blue arrow
back to Homepage
Something went wrong, please try again!